Aplagon doses first patient in phase 2a trial of APAC with peripheral arterial occlusive disease/chronic limb threatening ischemia: Helsinki, Finland Saturday, March 14, 2026, 18: ...
The Departments of Pathology and Pediatrics of Father Muller Medical College successfully conducted HAEM INSIGHT 3.0, a ...
Aplagon Announces First Patient Dosed in Phase 2a Clinical Trial of APAC in Patients with Peripheral Arterial Occlusive Disease / Chronic Limb Threatening Ischemia HELSINKI, 12 March 2026 - Aplagon, a ...
Diabetes and obesity drugs also lead to large reductions in adverse cardiovascular events, and the benefits aren’t just down ...
Epinephrine improves ROSC in cardiac arrest but does not increase favorable neurologic recovery, raising ethical and guideline questions for clinicians.
When we discuss bacterial infections, we often think of exotoxins—those soluble proteins actively secreted by bacteria—while overlooking endotoxins, which are more insidious but equally dangerous.
Aplagon has dosed the first patient in its phase 2a HEALING clinical trial evaluating APAC, a first‑in‑class treatment for thrombo‑inflammatory diseases, in people with peripheral arterial occlusive ...
As a common production contaminant, trace endotoxin triggers immune responses, skews results, and jeopardizes patient safety--risks that are critical in immunology, cell/gene therapy, and vaccine ...
While exotoxins dominate discussions of bacterial infections, endotoxins-cell wall components released upon bacterial death-are equally dangerous. These ...
Cannabis and other illicit drugs are associated with higher stroke risk, underscoring the importance of addressing substance ...
Antiplatelet drug therapy has become one of the cornerstones of treatment for patients with cardiovascular disease. Large clinical trials have shown that antiplatelet medications have important ...
Compared to a multivitamin, whole foods like leafy greens, fruits, whole grains, and fish contain nutrients that are better absorbed and used by the body. Learn more.